Efficacy and Safety of Hippophae Rhamnoides L. Leaf Extract on Body Fat
NCT ID: NCT02140697
Last Updated: 2016-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
80 participants
INTERVENTIONAL
2014-05-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Momordica Charantia Administration on Anthropometric Indicators in Patients With Obesity
NCT04916379
Efficacy and Safety of Actiponin on Antiobesity in Obese Korean Subjects.
NCT01667224
Effect of Intake of Glycin Max (L.) Merr. Peel Extract on Body Fat and Body Weight
NCT02108691
Benefit and Tolerability of IQP-LU-104 in Weight Loss
NCT03888911
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
NCT02041754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hippophae rhamnoides L. Leaf Extract
Hippophae rhamnoides L. Leaf Extract 3g/day
Hippophae rhamnoides L. Leaf Extract (3g/day)
Hippophae rhamnoides L. Leaf extract (3g/day), parallel design
Placebo
Placebo 3g/day
Placebo (3g/day)
Placebo (3g/day), parallel design
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hippophae rhamnoides L. Leaf Extract (3g/day)
Hippophae rhamnoides L. Leaf extract (3g/day), parallel design
Placebo (3g/day)
Placebo (3g/day), parallel design
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 25\~29.9 kg/m2 or Waist circumference ≥ 90(men), ≥ 85(women),
* subjects giving written informed consent
Exclusion Criteria
* Significant variation in weight(more 10%) in the past 3 months
* Cardiovascular disease, e.g. arrhythmia, heart failure, myocardial infarction, and patient with pacemaker
* History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease or gastrointestinal surgery
* Participation in any other clinical trials within past 2 months
* Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
* Pregnancy or breast feeding etc,.
19 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonbuk National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo-Wan Chae
Clinical Trial Center for Functional Foods
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SS-BF-HLE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.